about
Concordant and opposite roles of DNA-PK and the "facilitator of chromatin transcription" (FACT) in DNA repair, apoptosis and necrosis after cisplatinEGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatmentMre11 assembles linear DNA fragments into DNA damage signaling complexesInhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extractsDNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of CancerGenotypic characteristics of resistant tumors to pre-operative ionizing radiation in rectal cancerPreventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer TherapyRole of DNA-dependent protein kinase catalytic subunit in cancer development and treatmentChemical Inhibitors of Non-Homologous End Joining Increase Targeted Construct Integration in Cryptococcus neoformansGenome-wide screening of the genes required for tolerance to vanillin, which is a potential inhibitor of bioethanol fermentation, in Saccharomyces cerevisiaeBIOLOGICAL FUNCTIONALITY OF ELLAGIC ACID: A REVIEWPP6 regulatory subunit R1 is bidentate anchor for targeting protein phosphatase-6 to DNA-dependent protein kinaseVanillin inhibits translation and induces messenger ribonucleoprotein (mRNP) granule formation in saccharomyces cerevisiae: application and validation of high-content, image-based profiling.Orphan receptor TR3 enhances p53 transactivation and represses DNA double-strand break repair in hepatoma cells under ionizing radiation.Enzymatic oxidation of vanillin, isovanillin and protocatechuic aldehyde with freshly prepared Guinea pig liver slices.A comprehensive review on vanilla flavor: extraction, isolation and quantification of vanillin and others constituents.High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehydeAntimutagenicity of cinnamaldehyde and vanillin in human cells: Global gene expression and possible role of DNA damage and repair.The life and death of DNA-PK.AAV-mediated gene targeting is significantly enhanced by transient inhibition of nonhomologous end joining or the proteasome in vivoRadiation damage and radioprotectants: new concepts in the era of molecular medicineDNA-PK-mediated phosphorylation of EZH2 regulates the DNA damage-induced apoptosis to maintain T-cell genomic integrityOverview of the Role of Vanillin on Redox Status and Cancer Development.Vanilla--its science of cultivation, curing, chemistry, and nutraceutical properties.Replication independent DNA double-strand break retention may prevent genomic instabilityCisplatin associated with LY294002 increases cytotoxicity and induces changes in transcript profiles of glioblastoma cells.Targeting DNA-Dependent Protein Kinase for Cancer Therapy.Effect of the o-methyl catechols apocynin, curcumin and vanillin on the cytotoxicity activity of tamoxifen.Small Molecules, Inhibitors of DNA-PK, Targeting DNA Repair, and Beyond.Camptothecin enhances the frequency of oligonucleotide-directed gene repair in mammalian cells by inducing DNA damage and activating homologous recombination.HPV 5 and 8 E6 expression reduces ATM protein levels and attenuates LINE-1 retrotransposition.Effect of pH on the inhibition of Listeria spp. by vanillin and vanillic acid.DNA-dependent protein kinase plays a central role in transformation of breast epithelial cells following alkylation damage.Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T Cells.The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.
P2860
Q24306623-44A30479-AAD9-46C5-8C82-38A62512D452Q24338426-AADC912D-7BD5-49B0-B171-B02B3BCB0032Q24796676-473A2BC9-6EF1-4B4D-AA80-AB0FC63E0168Q24797982-932D65D6-E4B3-4A3A-971C-B983B85E0F62Q26776513-96EFE809-5D6F-40D6-B2CF-E513ACDD2B5AQ27007505-04032804-E350-4470-AF5E-37E5B0F3029AQ28084568-018046FA-6AFC-4EFE-B093-EFD143EAD8EEQ28274124-337968E4-17CA-4836-BF09-F635F903B63FQ28554238-FD3BC931-3552-45B9-994E-2BD68FE270C5Q28754615-DB9FCB7C-0855-4D53-A202-8B6D025D9DF0Q29013634-A7B83B30-2D73-452F-8A5A-8673FB6E9DDDQ30421888-A2B0B97B-43FB-45D8-BF9B-4AECD451D141Q31116379-D34E7E06-D19E-4188-AD21-470EDB20CF50Q33636901-DD5FAB3D-6A64-458C-8404-99FEE519A313Q34554412-07E22566-257F-41A7-BFF5-03D9ACED32C2Q34691696-CD9D1144-AF7B-4C61-8EAF-B8A3387C48D6Q34980645-F2A03352-3100-4781-8609-D5F48713116EQ35955343-0D322613-3841-418D-A60E-D825E6734C31Q35980970-BBFEA364-5BD1-46D4-AE51-EAF5B4C20CF4Q36084471-BBFE64DC-FEB3-418D-BBBD-3D2138FEA861Q36364394-F6EDFCEE-8875-4FEF-9521-8E03E19A236AQ37151491-5B3F8FDD-09A6-4765-A556-6F88451DBB47Q37548149-76AD7863-C3E7-4D20-98D8-6796A29BF448Q38148776-7D76C080-9EF1-4C20-8016-93B817D1E573Q38345239-E2295FF8-77E8-46CD-A167-BDC617A2E88CQ39064313-079CD6B0-B9D9-4BCB-8F2B-AEB5480FE6D2Q39250742-7DA7B7D1-9F7C-4FBF-9718-95A4806025F8Q39360764-C43A2003-CE68-4A0E-B28D-FC0ECE29865DQ39471754-4CDBEF0A-A2EB-43A7-AFE4-4F1B63676260Q40156233-4ADF0AF5-F029-440F-87CD-04E3185176DCQ41838838-1C4FF10C-29DF-4837-9A2A-41009515480EQ46597540-42E6D3B3-F211-4DA8-8EE1-8FBD2342552AQ47782486-EAEB34BA-9AB1-452B-954C-8FF2667340F7Q52430325-D51817ED-84C0-4C4D-BB76-7BE20C06756EQ55332403-124D1F27-3843-4C27-A148-9EF5DBE2BBA4
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Vanillins--a novel family of DNA-PK inhibitors.
@en
Vanillins--a novel family of DNA-PK inhibitors.
@nl
type
label
Vanillins--a novel family of DNA-PK inhibitors.
@en
Vanillins--a novel family of DNA-PK inhibitors.
@nl
prefLabel
Vanillins--a novel family of DNA-PK inhibitors.
@en
Vanillins--a novel family of DNA-PK inhibitors.
@nl
P2860
P356
P1476
Vanillins--a novel family of DNA-PK inhibitors.
@en
P2093
Peter Karran
Stephen Durant
P2860
P304
P356
10.1093/NAR/GKG753
P577
2003-10-01T00:00:00Z